Mathieu M, Steghens J P, Hørder M, Moss D W, Colinet E, Profilis C
Hospices Civils de Lyon, Hôpital Debrousse, Service de Biochimie, France.
Clin Chem. 1993 Sep;39(9):1894-8.
Creatine kinase (CK; EC 2.7.3.2) catalytic activity in serum is widely measured in clinical chemistry practice and provides information for diagnosis and follow-up in many pathological conditions affecting heart, muscle, and brain. Depending on the organ involved, the predominant CK isoenzyme in serum varies. However, routine methods measure total CK catalytic activity, and standardized methods for doing so have been recommended by the International Federation of Clinical Chemistry and by several national scientific societies. Many commercial kits for those methods are now available. With use of a reference material for CK, commercial reagents can be compared with standardized methods, improving confidence in the results. Here we present a reference preparation of CK consisting of the BB isoenzyme purified from human placentae. We describe the procedure of purification and the properties of the lyophilized preparation of CK-BB, which has been certified by the Community Bureau of Reference of the Commission of the European Communities under the designation CRM 299. The preparation can be used to calibrate assays of the catalytic activity of CK-MM and CK-MB, as well as CK-BB.
肌酸激酶(CK;EC 2.7.3.2)在血清中的催化活性在临床化学实践中被广泛测定,并为影响心脏、肌肉和大脑的许多病理状况的诊断和随访提供信息。根据所涉及的器官不同,血清中主要的CK同工酶也有所不同。然而,常规方法测量的是总CK催化活性,国际临床化学联合会以及几个国家科学协会已推荐了用于此目的的标准化方法。现在有许多用于这些方法的商业试剂盒。通过使用CK的参考物质,可以将商业试剂与标准化方法进行比较,从而提高对结果的可信度。在此,我们展示了一种由从人胎盘中纯化的BB同工酶组成的CK参考制剂。我们描述了纯化过程以及冻干的CK-BB制剂的特性,该制剂已获得欧洲共同体委员会参考局认证,编号为CRM 299。该制剂可用于校准CK-MM、CK-MB以及CK-BB催化活性的检测。